Concise review: Cell therapy and tissue engineering for cardiovascular disease

Stem Cells Translational Medicine

Volumn 1, Issue 2, 2012, Pages 136-141

  Haraguchi, Yuji ^a   Shimizu, Tatsuya ^a   Yamato, Masayuki ^a   Okano, Teruo ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Autologous stem cell transplantation; Cell transplantation; Stem progenitor cell; Tissue regeneration; Transplantation

Indexed keywords

ATAXIN 1; CHEMOKINE RECEPTOR CXCR4; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL REGENERATION; CELL SURVIVAL; CELL THERAPY; CORONARY ARTERY BYPASS GRAFT; EMBRYONIC STEM CELL; FIBROSIS; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HUMAN; META ANALYSIS (TOPIC); MYOBLAST; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVIEW; TISSUE ENGINEERING; TISSUE TRANSPLANTATION;

EID: 84871428717     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0030     Document Type: Review

References (99)

1. Lloyd-Jones D, Adams RJ, Brown TM et al. Executive summary: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 2010; 121:948-954.
2. Menasché P, Hagege AA, Scorsin M et al. Myoblast transplantation for heart failure. Lancet 2001;357:279-280.
3. Menasché P, Alfieri O, Janssens S et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: First randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-1200.
4. Opie SR, Dib N. Surgical and catheter delivery of autologous myoblasts in patients with congestive heart failure. Nat Clin Pract Cardiovasc Med 2006;3:S42-45.
5. Alaiti MA, Ishikawa M, Costa MA. Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy. Transl Res 2010;156:112-129.
6. Li RK, Jia ZQ, Weisel RD et al. Survival and function of bioengineered cardiac grafts. Circulation 1999;100:II63-II69.
7. Leor J, Aboulafia-Etzion S, Dar A et al. Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation 2000;102(19 Suppl 3):III56-III61.
8. Zimmermann WH, M Didie, Döker S et al. Heart muscle engineering: An update on cardiac muscle replacement therapy. Cardiovasc Res 2006;71:419-429.
9. Atala A, Lanza R, Thomson JA et al. Principles of Regenerative Medicine. In: Radisic M, Michael VM, ed. Cardiac Tissue. 2nd ed. New York: Academic Press, 2011:877-909.
10. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
11. Masuda S, Shimizu T, Yamato M et al. Cell Sheet Engineering For Heart Tissue Repair. Adv Drug Deliver Rev 2008;60:277-285.
12. Matsuda N, Shimizu T, Yamato M et al. Tissue engineering based on cell sheet technology. Adv Mater 2007;19:3089-3099.
13. Boron WF, Boulpaep EL. Medical physiology. In: Radisic M, Michael VM, ed. The Cardiovascular System. Philadelphia, PA: Elsevier Science, 2003:1-1319.
14. Brueckner JK, Carmichael SW, Gest TR et al. Atlas of Human Anatomy. 4th ed. Philadelphia, PA: Elsevier Science, 2006.
15. Soejitno A, Wihandani DM, Kuswardhani RA. Clinical applications of stem cell therapy for regenerating the heart. Acta Med Indones 2010;42:243-257.
16. Rota M, Padin-Iruegas ME, Misao Y et al. Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res 2008;103:107-116.
17. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
18. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861-872.
19. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
20. Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414.
21. Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-2740.
22. Yang L, Soonpaa MH, Adler ED et al. Human cardiovascular progenitor cells develop from a KDR embryonic-stem-cellderived population. Nature 2008;453:524-528.
23. Yoshida Y, Yamanaka S. iPS cells: A source of cardiac regeneration. J Mol Cell Cardiol 2011;50:327-332.
24. Passier R, Oostwaard DW, Snapper J et al. Increased cardiomyocyte differentiation from human embryonic stem cells in serumfree cultures. STEM CELLS 2005;23:772-780.
25. Graichen R, Xu X, Braam SR et al. Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 2008;76:357-370.
26. Xu XQ, Graichen R, Soo SY et al. Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation 2008;76:958-970.
27. Shimoji K, Yuasa S, Onizuka T et al. G-CSF Promotes the proliferation of developing cardiomyocytes in vivo and in derivation from ESCs and iPSCs. Cell Stem Cell 2010;6:227-237.
28. Fujiwara M, Yan P, Otsuji TG et al. Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with Cyclosporin-A. PLoS One 2011;6:e16734.
29. Xu C, Police S, Rao N et al. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 2002;91:501-508.
30. Laflamme MA, Gold J, Xu C et al. Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol 2005;167:663-671.
31. Kita-Matsuo H, Barcova M, Prigozhina N et al. Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes. PLoS One 2009;4:e5046.
32. Hattori F, Chen H, Yamashita H et al. Nongenetic method for purifying stem cellderived cardiomyocytes. Nat Methods 2010;7: 61-66.
33. Kehat I, Khimovich L, Caspi O et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004;22:1282-1289.
34. Caspi O, Huber I, Kehat I et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol 2007;50:1884-1893.
35. Dai W, Field LJ, Rubart M et al. Survival and maturation of human embryonic stem cellderived cardiomyocytes in rat hearts. J Mol Cell Cardiol 2007;43:504-516.
36. Laflamme MA, Chen KY, Naumova AV et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-1024.
37. van Laake LW, Passier R, MonshouwerKloots J et al. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007;1:9-24.
38. Bretzner F, Gilbert F, Baylis F et al. Target populations for first-in-human embryonic stem cell research in spinal cord injury. Cell Stem Cell 2011;8:468-475.
39. Badorff C, Brandes RP, Popp R et al. Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024-1032.
40. Koyanagi M, Bushoven P, Iwasaki M et al. Notch signaling contributes to the expression of cardiac markers in human circulating progenitor cells. Circ Res 2007;101:1139-1145.
41. Gruh I, Beilner J, Blomer U et al. No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006;113:1326-1334.
42. Psaltis PJ, Zannettino AC, Worthley SG et al. Concise review: Mesenchymal stromal cells: Potential for cardiovascular repair. Stem Cells 2008;26:2201-2210.
43. Hida N, Nishiyama N, Miyoshi S et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells. STEM CELLS 2008;26:1695-1704.
44. Planat-Bénard V, Menard C, André M et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res 2004; 94:223-229.
45. Gimble JM, Katz AJ, Bunnell BA. Adiposederived stem cells for regenerative medicine. Circ Res 2007;100:1249-1260.
46. Beltrami AP, Barlucchi L, Torella D et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114:763-776.
47. Oh H, Bradfute SB, Gallardo TD et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sc i U S A 2003;100: 12313-12318.
48. Bergmann O, Bhardwaj RD, Bernard S et al. Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102.
49. Lee ST, White AJ, Matsushita S et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol 2011;57:455-465.
50. Abdel-Latif A, Bolli R, Tleyjeh IM et al. Adult bone marrow-derived cells for cardiac repair: A systematic review and meta-analysis. Arch Intern Med 2007;167:989-997.
51. Lipinski MJ, Biondi-Zoccai GG, Abbate A et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007;50:1761-1767.
52. Martin-Rendon E, Brunskill SJ, Hyde CJ et al. Autologous bone marrow stem cells to treat acute myocardial infarction: A systematic review. Eur Heart J 2008;29:1807-1818.
53. Zhang M, Methot D, Poppa V et al. Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J Mol Cell Cardiol 2001;33:907-921.
54. Hofmann M, Wollert KC, Meyer GP et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005;111:2198-2202.
55. Shimizu T, Sekine H, Yamato M et al. Cell sheet-based myocardial tissue engineering: New hope for damaged heart rescue. Curr Pharm Des 2009;15:2807-2814.
56. Vunjak-Novakovic G, Tandon N, Godier A et al. Challenges in cardiac tissue engineering. Tissue Eng Part B Rev 2010;16:169-187.
57. Piao H, Kwon JS, Piao S et al. Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials 2007;28:641-649.
58. Tan M, Zhi YW, Wei RQ et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 2009;30:3234-3240.
59. Chachques JC, Trainini JC, Lago N et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM clinical trial): One year follow-up. Cell Transplant 2007;16:927-934.
60. Yamada N, Okano T, Sakai H et al. Thermo-responsive pol-ymeric surface: Control of attachment and detachment of cultured cells. Macromol Chem Rapid Commun 1990; 11:571-576.
61. Okano T, Yamada H, Sakai H et al. A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly (N-isopropylacrylamide). J Biomed Mater Res 1993;27:1243-1251.
62. Memon IA, Sawa Y, Fukushima N et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg 2005; 130:1333-1341.
63. Liu Y, Rajur K, Tolbert E et al. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int 2000;58:2028-2043.
64. Taniyama Y, Morishita R, Aoki M et al. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: Preclinical study for treatment of peripheral arterial disease. Gene Ther 2001;8:181-189.
65. Li Y, Takemura G, Kosai K et al. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 2003;107:2499-2506.
66. Hinkel R, Trenkwalder T, Kupatt C. Gene therapy for ischemic heart disease. Expert Opin Biol Ther 2011;11:723-737.
67. Lavu M, Gundewar S, Lefer DJ. Gene therapy for ischemic heart disease. J Mol Cell Cardiol 2011;50:742-750.
68. Askari AT, Unzek S, Popovic ZB et al. Effect of stromal-cell-derived factor 1 on stemcell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003;362:697-703.
69. Yamaguchi J, Kusano KF, Masuo O et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003;107:1322-1328.
70. Sekiya N, Matsumiya G, Miyagawa S et al. Layered implantation of myoblast sheets attenuates adverse cardiac remodeling of the infarcted heart. J Thorac Cardiovasc Surg 2009; 138:985-993.
71. Kondoh H, Sawa Y, Miyagawa S et al. Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. Cardiovasc Res 2006;69:466-475.
72. Hata H, Matsumiya G, Miyagawa S et al. Grafted skeletal myoblast sheets attenuate myocardial remodeling in pacing-induced canine heart failure model. J Thorac Cardiovasc Surg 2006;132:918-924.
73. Miyagawa S, Saito A, Sakaguchi T et al. Impaired myocardium regeneration with skeletal cell sheets-A preclinical trial for tissueengineered regeneration therapy. Transplantation 2010;90:364-372.
74. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-465.
75. Matsuura K, Honda A, Nagai T et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 2009;119: 2204-2217.
76. Siltanen A, Kitabayashi K, Lakkisto P et al. hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure. PLoS One 2011;6:e19161.
77. Kobayashi H, Shimizu T, Yamato M et al. Fibroblast sheets co-cultured with endothelial progenitor cells improve cardiac function of infarcted hearts. J Artif Organs 2008;11:141-147.
78. Zimmermann WH, Schneiderbanger K, Schubert P et al. Tissue engineering of a differentiated cardiac muscle construct. Circ Res 2002;90:223-230.
79. Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006;12:452-458.
80. Zhao YS, Wang CY, Li DX et al. Construction of a unidirectionally beating 3-dimensional cardiac muscle construct. J Heart Lung Transplant 2005;24:1091-1097.
81. Engelmayr GC Jr., Cheng M, Bettinger CJ et al. Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater 2008;7:1003-1010.
82. Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: Using nature's platform to engineer a bioartificial heart. Nat Med 2008;14:213-221.
83. Shimizu T, Yamato M, Isoi Y et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002;90:e40.
84. Haraguchi Y, Shimizu T, Yamato M et al. Electrical coupling of cardiomyocyte sheets occurs rapidly via functional gap junction formation. Biomaterials 2006;27:4765-4774.
85. Shimizu T, Yamato M, Kikuchi A et al. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 2003;24:2309-2316.
86. Shimizu T, Sekine H, Isoi Y et al. Longterm survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng 2006;12: 499-507.
87. Sekine H, Shimizu T, Kosaka S et al. Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells. J Heart Lung Transplant 2006;25:324-332.
88. Miyagawa S, Sawa Y, Sakakida S et al. Tissue cardiomyoplasty using bioengineered contractile cardiomyocyte sheets to repair damaged myocardium: Their integration with recipient myocardium. Transplantation 2005; 80:1586-1595.
89. Sekiya S, Shimizu T, Yamato M et al. Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. Biochem Biophys Res Commun 2006;341:573-582.
90. Sekine H, Shimizu T, Hobo K et al. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 2008;118:S145-S152.
91. Shin M, Ishii O, Sueda T et al. Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials 2004;25:3717-3723.
92. Itabashi Y, Miyoshi S, Kawaguchi H et al. A new method for manufacturing cardiac cell sheets using fibrin-coated dishes and its electrophysiological studies by optical mapping. Artif Organs 2005;29:95-103.
93. Ito A, Hibino E, Kobayashi C et al. Construction and delivery of tissue-engineered human retinal pigment epithelial cell sheets, using magnetite nanoparticles and magnetic force. Tissue Eng 2005;11:489-496.
94. Huang YC, Khait L, Birla RK. Contractile three-dimensional bioengineered heart muscle for myocardial regeneration. J Biomed Mater Res A 2007;80:719-731.
95. Caspi O, Lesman A, Basevitch Y et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ Res 2007;100:263-272.
96. Stevens KR, Pabon L, Muskheli V et al. Scaffold-free human cardiac tissue patch created from embryonic stem cells. Tissue Eng Part A 2009;15:1211-1222.
97. Chen QZ, Ishii H, Thouas GA et al. An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials 2010;31:3885-3893.
98. Tulloch NL, Muskheli V, Razumova MV et al. Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res 2011;109:47-59.
99. Eschenhagen T. The Beat Goes On: Human heart muscle from pluripotent stem cells. Circ Res 2011;109:24.